On February 13, 2013, our Canadian pharmacist received the corrected import permit from Health Canada, after working for more than 2½ years to make the required security adjustments to the pharmacy. The previous permit erroneously listed the manufacturer rather than the supplier on the form. Finally, after working more than three years, our Swiss MDMA supplier will now finally request an export permit.
Co-Principal Investigator Andrew Feldmár, M.A., will give an update on our planned Canadian study at Psychedelic Science 2013, if the U.S. Embassy gives him permission to enter the country.